These two names get treated like competing substances, and they aren't. Psilocybin and psilocin are two stages of the same process — one becomes the other inside your body. Here's what's actually happening, and why the distinction is worth understanding.
Key Takeaways
- Psilocybin is a prodrug — inactive until your body converts it into psilocin
- Psilocin is the compound that actually produces the effects, by activating serotonin receptors
- They aren’t alternatives to compare — psilocybin is essentially the delivery form of psilocin
- Mushroom potency varies widely, which is why “the same amount” can produce very different experiences
Why This Isn't Really a Comparison
Most "psilocybin vs. psilocin" content treats these as two options to weigh against each other. That's a category error. Psilocybin doesn't do anything on its own — it's a prodrug, meaning it's inactive until the body chemically converts it. What it converts into is psilocin, and psilocin is what produces every effect people associate with psychedelic mushrooms [1].
| Psilocybin | Psilocin | |
|---|---|---|
| What it is | A prodrug — inactive as-is | The active compound |
| Where it’s found | In the mushroom itself | Produced in your body from psilocybin (also present in small amounts in fresh mushrooms) |
| Does it cause effects? | Not directly — it must convert first | Yes — this is what acts on the brain |
| Stability | More stable | Less stable; degrades more readily |
| How it acts | Converted after ingestion | Crosses into the brain and activates serotonin 5-HT2A receptors |
How the Conversion Works
After ingestion, enzymes strip a phosphate group off the psilocybin molecule, producing psilocin. That change makes the molecule better able to cross into the brain, where it activates serotonin receptors — primarily the 5-HT2A receptor — producing the shifts in perception, mood, and thinking associated with psychedelics [1][2].
Why the Distinction Matters
Mostly it explains variability. Psilocybin is the more stable of the two, while psilocin degrades more readily — which is one reason mushroom potency differs so much between batches, storage conditions, and whether they're fresh or dried [3]. In practice, "the same amount" is rarely the same amount, and that unpredictability is the honest safety point buried inside this technical question.
The Risks Worth Knowing
Psychedelic mushrooms don't typically produce physical dependence the way alcohol or opioids do, and tolerance builds quickly enough that frequent use tends to be self-limiting. That doesn't make them harmless. Difficult experiences can leave lasting anxiety, and for people with a personal or family history of psychosis or bipolar disorder, psychedelics may precipitate or worsen symptoms.
There's also a practical risk this page's technical framing can obscure: what's sold as mushrooms isn't always mushrooms, and misidentified wild species can be genuinely poisonous. If you want the fuller picture on that, see our guide to what "pure" really means in an unregulated supply.
When Mushroom Use Becomes a Problem
To be straightforward about scope: psychedelic use on its own usually isn't something we admit as a primary diagnosis. Where we can genuinely help is the far more common situation — mushroom use happening alongside other substances, or alongside anxiety, depression, or trauma that's driving it. Our dual-diagnosis programs treat both together.
If you're worried about someone else, our Families & Loved Ones team can help you think through how to raise it.
If someone is in acute distress, unresponsive, or may have eaten a misidentified wild mushroom, call 911 — some species are genuinely poisonous. If this brings up thoughts of suicide or self-harm, call or text 988, the Suicide & Crisis Lifeline.
FAQs
- What’s the difference between psilocybin and psilocin?
- Psilocybin is a prodrug — it’s inactive until your body converts it into psilocin, which is the compound that actually produces the effects. They aren’t two alternatives; they’re two stages of the same process.
- Is psilocin stronger than psilocybin?
- It’s not really a strength comparison. Psilocin is the active form, so all of psilocybin’s effects happen through it — psilocybin is essentially the delivery mechanism. Asking which is stronger is a bit like asking whether a letter or its contents carries the message.
- Which one is in magic mushrooms?
- Both, though psilocybin is the dominant compound in dried mushrooms because it’s more stable. Fresh mushrooms contain some psilocin as well, but it degrades more readily, which is part of why potency varies so much between batches.
- How does psilocin affect the brain?
- After conversion, psilocin crosses into the brain and activates serotonin receptors — primarily the 5-HT2A receptor — which is what produces the changes in perception, mood, and thinking associated with psychedelic mushrooms.
- Are psychedelic mushrooms addictive?
- They don’t typically cause physical dependence the way alcohol or opioids do, and tolerance builds quickly, which tends to limit frequent use. That doesn’t make them risk-free — psychological reliance is possible, and difficult experiences can have lasting mental health effects, particularly for someone already vulnerable.
- Can mushroom use trigger mental health problems?
- It can, especially for people with a personal or family history of psychosis or bipolar disorder, where psychedelics may precipitate or worsen symptoms. Distressing experiences can also leave lingering anxiety. If use is tangled up with an existing mental health condition, that combination is worth treating together.
- Does Virtue treat psychedelic use?
- Psychedelic use on its own usually isn’t something we admit as a primary diagnosis. Where we can genuinely help is when it’s happening alongside other substance use or an underlying mental health condition — that’s what our dual-diagnosis programs are built for, and it’s how this most often shows up in practice.
- Does insurance cover dual-diagnosis treatment?
- Most major plans cover medically necessary treatment for co-occurring substance use and mental health conditions. You can verify your coverage for free in a few minutes.
Sources
- National Institute on Drug Abuse (NIDA). Psilocybin (Magic Mushrooms).
- Frontiers in Pharmacology. In Vitro and In Vivo Metabolism of Psilocybin’s Active Metabolite Psilocin.
- PMC, National Library of Medicine (NIH). Synthesis and In Vitro Profiling of Psilocin Derivatives: Improved Stability and Synthetic Properties.
This article is for informational purposes only and is not a substitute for professional medical advice.
Written by
Executive Director
Dominic Perry is a Licensed Clinical Social Worker (LCSW), Licensed Clinical Alcohol and Drug Counselor (LCADC), Master Addiction Counselor (MAC), and DOT Substance Abuse Professional (SAP) with approximately eight years of experience in behavioral health and substance use treatment. Dominic began his work with Virtue as a therapist at the Corbett residential facility before progressing into leadership, and now serves as Executive Director of Virtue Recovery Center – Outpatient in Las Vegas. He earned his Bachelor of Social Work from UNLV and his Master of Social Work from the University of Nevada Reno.
Read Full Bio →
